Biochemists Discover Olive Oil Link to Assist Diabetes and Weight Loss

Food and Healthcare Press Releases Thursday October 5, 2017 14:13
Bangkok--5 Oct--Hill+Knowlton Strategies
For Thailand's 19 million overweight nationals, and four million diabetes sufferers[1], new scientific evidence shows how the consumption of Olive oil can assist in both weight loss and diabetes management.

With diabetes and obesity on the rise in Thailand, a US Virginia Tech research team recently isolated for the first time exactly why Olive oil presents a low-cost method to help diabetes prevention and assist loss of unhealthy body mass[2]. 'Oleuropein' a compound in Olive oil, was proven to support the body to secrete more insulin – a molecule that controls metabolism and blood sugar levels. With the 32% of Thailand's population deemed 'overweight,' and 7.7 million at risk of developing diabetes on top of the estimated four million who are already diagnosed1, , the findings come at a crucial juncture in the nation's mounting battle with NCDs.

"Our work provides new mechanistic insights into the long-standing question of why olive products can be anti-diabetic," says Dr. Bin Xu, assistant professor at Virginia Tech. "We believe it will have an impact on the public to pay more attention to olive products in light of the current diabetes epidemic."

The latest study, published in the Biochemistry journal by the American Chemical Society, was able to pinpoint that a type of phenolic bitter compound found in olives, assists the body to secrete increased insulin levels. The rise of this hormone allows cells to more easily use sugar for energy.

Furthermore, insulin acts as a signaling molecule in the body that controls metabolism, and when released makes it more difficult for the body to store fat and put on weight. The same Oleuropein compound also inhibits the cytotoxicity induced by 'amylin,' a harmful molecule feature found in type 2 diabetes sufferers.

Olive oil has long been attributed as one of the key international diet factors in assisting long life expectancy and health[3]. But previously the exact biochemical factors behind its health-giving properties had not been isolated. Thus, the findings provide Thais at risk of diabetes or obesity an easy method to prevent and regulate the onset of diabetes and assist in weight reduction by eating Olive oil regularly as part of a balanced diet.

"We have always known that Olive oil presents many health and nutritional benefits. But to have a study of this calibre explain the exact active compound in Olive oil that can help both diabetes and weight loss, is knowledge that we hope can easily assist our Bertolli Olive oil customers in Thailand, if they would like to lead healthier lives," says Mr. Alberto Perez Martin, Head of Bertolli Thailand and Asia, the leading Olive oil brand in Thailand.


Latest Press Release

ESMO Publishes New Position Paper on Supportive and Palliative Care

ESMO, the leading professional organisation for medical oncology, published a position paper on supportive and palliative care [ https://doi.org/10.1093/annonc/mdx757 ], calling attention to the evolving and growing gap between the needs of cancer...

Koch Disruptive Technologies to Lead $150 Million Investment of INSIGHTEC

The medical device company is transforming neurological treatments through its non-invasive focused ultrasound applications Koch Disruptive Technologies, a subsidiary of Koch Industries focused on finding and funding innovative and emerging companies,...

MediaTek Sensio: New Biosensor Solution Brings Health Monitoring to Smartphones

MediaTek Inc. today unveiled MediaTek Sensio(TM), the first 6-in-1 smartphone biosensor module. MediaTek Sensio is a powerful advanced health monitoring solution which makes it easy to track heart rate information, blood pressure trends, peripheral...

Merck Signs Distribution Agreement with Avanti(R) Polar Lipids

Merck , a leading science and technology company, today announced that it has entered into an agreement with Avanti(R) Polar Lipids to be the exclusive multinational distributor of the USA-based company's research lipids portfolio outside of the United...

Xultophy(R) Significantly Reduces Blood Sugar Levels, Body Weight and Risk of Hypoglycaemia for People With Type 2 Diabetes in Real-World Setting

Newly published data from real-world European clinical practice has shown that Xultophy(R) (insulin degludec/liraglutide) significantly reduced blood sugar levels in people with type 2 diabetes after six months.[1] The study looked at people with type 2...

Related Topics